Invesco’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.99M Buy
1,422,317
+170,652
+14% +$546K ﹤0.01% 2191
2025
Q4
$3.42M Buy
1,251,665
+306,195
+32% +$708K ﹤0.01% 2407
2025
Q3
$2.05M Buy
945,470
+291,521
+45% +$688K ﹤0.01% 2599
2025
Q2
$1.12M Buy
653,949
+319,692
+96% +$795K ﹤0.01% 2798
2025
Q1
$1.11M Buy
334,257
+112,329
+51% +$579K ﹤0.01% 2788
2024
Q4
$1.64M Buy
221,928
+4,967
+2% +$46K ﹤0.01% 2689
2024
Q3
$2.04M Buy
216,961
+2,892
+1% +$27.4K ﹤0.01% 2591
2024
Q2
$1.72M Sell
214,069
-2,729
-1% -$29.2K ﹤0.01% 2655
2024
Q1
$3.21M Sell
216,798
-620,360
-74% -$7.22M ﹤0.01% 2453
2023
Q4
$6.81M Buy
837,158
+686,067
+454% +$3.59M ﹤0.01% 2061
2023
Q3
$687K Buy
151,091
+6,453
+4% +$42.1K ﹤0.01% 3047
2023
Q2
$1.02M Buy
144,638
+2,449
+2% +$17.5K ﹤0.01% 2889
2023
Q1
$869K Buy
142,189
+45,375
+47% +$313K ﹤0.01% 2959
2022
Q4
$619K Sell
96,814
-364
-0.4% -$2.84K ﹤0.01% 3178
2022
Q3
$931K Sell
97,178
-1,541,077
-94% -$17.8M ﹤0.01% 2958
2022
Q2
$18.1M Sell
1,638,255
-23,037
-1% -$302K 0.01% 1432
2022
Q1
$27.7M Buy
1,661,292
+74,225
+5% +$1.15M 0.01% 1295
2021
Q4
$30.3M Buy
1,587,067
+560,410
+55% +$12.3M 0.01% 1290
2021
Q3
$25.3M Sell
1,026,657
-7,708
-0.7% -$182K 0.01% 1426
2021
Q2
$26.9M Sell
1,034,365
-133,507
-11% -$3.47M 0.01% 1415
2021
Q1
$37M Sell
1,167,872
-437,391
-27% -$18.1M 0.01% 1203
2020
Q4
$74.5M Buy
1,605,263
+27,447
+2% +$1.09M 0.02% 872
2020
Q3
$51.9M Buy
1,577,816
+352,995
+29% +$10.8M 0.02% 925
2020
Q2
$33.6M Buy
1,224,821
+1,040,995
+566% +$34.2M 0.01% 1072
2020
Q1
$5.5M Buy
183,826
+67,895
+59% +$1.8M ﹤0.01% 1823
2019
Q4
$3.21M Buy
+115,931
New +$2.64M ﹤0.01% 2421
2019
Q3
Sell
-133,591
Closed -$3.28M 3698
2019
Q2
$3.28M Buy
+133,591
New +$2.01M ﹤0.01% 2428
2018
Q3
Sell
-315,330
Closed -$4.04M 3901
2018
Q2
$4.04M Buy
+315,330
New +$4.61M ﹤0.01% 2275
2015
Q3
Sell
-569
Closed -$5K 3882
2015
Q2
$5K Buy
+569
New +$6.35K ﹤0.01% 4201

Other funds holding IOVA